Author: | White, D. A. |
Article Title: | Drug-induced pulmonary infection |
Abstract: | Immunosuppressive drugs lead to an enhanced risk for infection. The impact of these drugs on the immune system can be broad (eg, corticosteroids) or targeted (eg, rituximab). Infections can have serious consequences, particularly if there is a delay in diagnosis. It is hoped that a knowledge of the type of immune defects that are induced by these drugs and the specific infections that have been reported will guide clinicians in the appropriate use of prophylactic regimens and diagnostic considerations in the event of pneumonia. |
Keywords: | antibiotic agent; fludarabine; prednisone; review; methotrexate; rituximab; chemoprophylaxis; immunoglobulin; pneumocystis pneumonia; antiinfective agent; mycobacterium tuberculosis; tumor necrosis factor-alpha; etanercept; glucocorticoid; purine derivative; corticosteroid; immunosuppressive treatment; tacrolimus; lung infection; ganciclovir; cytomegalovirus infection; cyclosporin; cyclosporine; immunosuppressive agents; voriconazole; cytomegalovirus; infection risk; aspergillosis; lung aspergillosis; alemtuzumab; listeriosis; listeria monocytogenes; pentostatin; legionella; tuberculosis; bronchitis; opportunistic infection; itraconazole; cladribine; glucocorticoids; histoplasmosis; lung diseases; lung tuberculosis; communicable diseases; bacterial pneumonia; infliximab; pneumocystis carinii; purine nucleosides; pneumonia, pneumocystis; humans; human; priority journal; nocardia; nocardiosis |
Journal Title: | Clinics in Chest Medicine |
Volume: | 25 |
Issue: | 1 |
ISSN: | 0272-5231 |
Publisher: | Elsevier Inc. |
Date Published: | 2004-03-01 |
Start Page: | 179 |
End Page: | 187 |
Language: | English |
DOI: | 10.1016/s0272-5231(03)00134-5 |
PROVIDER: | scopus |
PUBMED: | 15062609 |
DOI/URL: | |
Notes: | Clin. Chest Med. -- Cited By (since 1996):22 -- Export Date: 16 June 2014 -- CODEN: CCHMD -- Source: Scopus |